MYRIAD GENETICS INC.

Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2

20 Nov 2024 15:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

20 Nov 2024 08:52:22 By NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

19 Nov 2024 09:20:58 By NetDania Notify

Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy

19 Nov 2024 07:00:01 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

18 Nov 2024 08:46:05 By NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

15 Nov 2024 08:49:49 By NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

14 Nov 2024 08:54:04 By NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

13 Nov 2024 10:10:23 By NetDania Notify

Myriad Genetics Expands Access to At-Home Early Fetal Sex DNA Test with Retail Launch

13 Nov 2024 07:00:01 By Nasdaq GlobeNewswire

Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance

07 Nov 2024 15:05:02 By Nasdaq GlobeNewswire

Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing

04 Nov 2024 07:39:37 By Nasdaq GlobeNewswire

Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 2024

30 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access

16 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

Myriad Genetics and Flatiron Health Partner to Make Genetic Testing More Accessible with Electronic Medical Record Integration

15 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer

08 Oct 2024 15:05:00 By Nasdaq GlobeNewswire

Myriad Genetics and Ultima Genomics to Explore the UG 100™ Sequencing Platform to Advance Clinical Test Offerings in Oncology and Reproductive Genomics

03 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

01 Oct 2024 15:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

18 Sep 2024 10:03:42 By NetDania Notify

Myriad Genetics to Share New Data Highlighting Genetic Testing Advancements at 2024 National Society of Genetic Counselors Annual Conference

18 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

Myriad Genetics to Host Investor Event on October 9, 2024

05 Sep 2024 07:00:00 By Nasdaq GlobeNewswire